Initial response to the Long Term Plan
Sector response to the Long Term Plan has now been published and it has been welcomed in the main, though cautiously by some. The NHS...
NHS long term plan: making the NHS fit for the future
The NHS long term plan, published today, will save almost half a million more lives with practical action on major killer conditions and investment...
Could a new breath test detect multiple cancers earlier?
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. This...
Changes to pharma and healthcare in 2019
Continuing funding shortages, Brexit uncertainty, regulator moves and regulation reforms: there is no shortage of change facing the sector in 2019. We asked the industry’s...
The effects of the NHS 10-Year Plan on pharma
Horizon scanning: What’s on the agenda for healthcare in 2019 and what does this mean for pharma? NHS Forward View As we enter into a new...
Health management tips for men
Dr Andrew Thornber’s health management tips for men
1. Dont rely on Dr Search When it comes to health, there can be a lot of information...
Improving primary care with community pharmacy
James Roach evaluates how partnership working between a community pharmacy and primary care setting has significant potential if scaled up. Working with the National Pharmacy Association;...
NHS e-Referral Service makes its 100 millionth online booking
The NHS e-Referral Service has hit 100 million bookings since it was launched in 2005 as the NHS Choose and Book Service. Currently, the service...
£1M grant scheme for rare diseases
Great Ormond Street Hospital Children’s Charity (GOSH Charity) and LifeArc have launched a £1M grant scheme for rare disease patients. The new joint funding scheme Translational Research Accelerator Grants is...
Non-invasive MRI diagnostic method for prostate cancer approved by NICE
A non-invasive MRI diagnostic method for prostate cancer has been approved by the National Institute for Health and Care Excellence (NICE). The scanning technique will...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...